Usama Gergis

Thomas Jefferson University Hospital

H指数:31

被引数:3,709

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decentralized CAR-T production: clinical, economic, and regulatory perspectives. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article

去中心化CAR-T生产：临床、经济和监管视角。世界血液与骨髓移植网络（WBMT）专题文章

Bone Marrow Transplantation

IF5.2

2026-09-240

PRE

Abdulrahman Nasiri; Riad El Fakih; Christian Chabannon; Laurent Garderet; Jurgen Kuball; Ali Bazarbachi; Anna Sureda; Marcos De Lima; Muhammad Bilal Abid; Farhatullah Syed; Ibrahim N. Muhsen; Daniel Weisdorf; Hildegard T. Greinix; Anna Ossami Saidy; Mohammad Alhomoud; Abdulwahab Albabtain; Helen Baldomero; Shahrukh Hashmi; Lorenz Thurner; Nina Worel; Adrian Seber; Sebastian Galeano; Usama Gergis; Raheel Iftikhar; Yoshihisa Kodera; Marcelo Pasquini; Yoshiko Atsuta; Syed Osman Ahmed; Damiano Rondelli; Mohamad Mohty; John A. Snowden; Ibrahim Yakoub Agha; Mohamed Kharfan-Dabaja; Dietger Niederwieser; Mickey Koh; Mahmoud Aljurf

Epigenetic Priming with Azacitidine Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies

在骨髓恶性肿瘤患者异基因造血干细胞移植前采用阿扎胞苷进行表观遗传预激

Transplantation and Cellular Therapy

IF4.4

2026-08-150

PRE

The Heart of the Matter: Cardiac Toxicity in Allogenic Stem Cell Transplant with Post-Transplant Cyclophosphamide

核心问题：异基因干细胞移植伴移植后环磷酰胺的心脏毒性

Transplantation and Cellular Therapy

IF4.4

2025-10-270

PRE

Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis

嵌合抗原受体T细胞疗法治疗Richter转化：一项CIBMTR分析

Transplantation and Cellular Therapy

IF4.4

2025-08-050

PRE

Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation

更正：在资源有限国家中，使用非冷冻保存的自体外周血干细胞移植治疗多发性骨髓瘤和淋巴瘤：来自世界骨髓移植联盟的实践考量

Bone Marrow Transplantation

IF5.2

2025-06-300

PRE

Mohamed Amine Bekadja; Dietger Niederwieser; Mohamed A. Kharfan-Dabaja; Riad El Fakih; Laurent Garderet; Ibrahim Yakoub-Agha; Hildegard Greinix; Daniel J. Weisdorf; Sebastian Galeano; Syed Osman Ahmed; Christian Chabanon; Shahrukh K. Hashmi; Annalisa Ruggeri; Usama Gergis; Ali Bazarbachi; Nada Hamad; Amal Albeihany; Marcelo Pasquini; Amr Hanbali; Jeff Szer; Yoshihisa Kodera; Ambuj Kumar; Tusneem Elhassan; Donal McLornan; Nina Worel; Raffaella Greco; Mohamad Mohty; Yoshiko Atsuta; Mickey Koh; Anna Sureda; Damiano Rondelli; Mahmoud Aljurf; Walid Rasheed

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

CD19嵌合抗原受体T细胞疗法治疗大B细胞淋巴瘤后的感染：CIBMTR的真实世界分析

Blood Advances

IF7.1

2025-05-300

OAAI

Kitsada Wudhikarn; Megan M. Herr; Min Chen; Michael J. Martens; John H. Baird; Lohith Gowda; Hemalatha G. Rangarajan; Muhammad Bilal Abid; Mohamed A. Kharfan-Dabaja; Kirsten M. Williams; Siddhartha Ganguly; Jo-Anne H. Young; Akshay Sharma; Giancarlo Fatobene; Tania Jain; Christopher G. Kanakry; Dipenkumar Modi; Natalie S. Grover; Baheyeldin Salem; Marjorie Vieira Batista; Paschalis Vergidis; Dwight E. Yin; Amer M. Beitinjaneh; Amar H. Kelkar; Taiga Nishihori; Jennifer Holter Chakrabarty; Usama Gergis; Melody Smith; Zeinab El Boghdadly; Christopher E. Dandoy; Hemant S. Murthy; Anna R. Huppler; Miguel-Angel Perales; Roy F. Chemaly; Joshua A. Hill; Marcie Riches; Jeffery J. Auletta

Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

真实世界（RW）结局：Brexucabtagene autoleucel（Brexu-Cel）治疗具有高风险特征及既往治疗史患者的复发或难治性B细胞急性淋巴细胞白血病（R/R B-ALL）结局；来自CIBMTR®登记数据的更新证据

BLOOD

IF23.1

2024-11-051

PRE

TBI-Based Myeloablative Conditioning Two-Step Haploidentical Allogeneic Hematopoietic Stem Cell Transplant Yields Excellent Outcomes in Fit Patients with High-Risk Hematologic Malignancies, Results of a Prospective Trial

BLOOD

IF23.1

2024-11-050

PRE

Letermovir Prophylaxis Is Effective in Preventing CMV Reactivation and Is Associated with Decreased Non-Relapse Mortality in Two-Step Allogeneic Stem Cell Transplantation

Letermovir预防在两步同种异基因干细胞移植中可有效防止CMV再激活，并与非复发死亡率降低相关。

BLOOD

IF23.1

2024-11-050

PRE

A Novel Chemo-Based Reduced Intensity Haploidentical Two-Step Allogeneic Hematopoietic Stem Cell Transplantation, Results of a Prospective Clinical Trial

一种新型基于化疗的减低强度单倍型两步法异基因造血干细胞移植，前瞻性临床 trial 结果

BLOOD

IF23.1

2024-11-050

PRE

A Tender Reduced-Intensity Conditioning for the Unfit: fi t: A Novel 4 Gy Total Body Irradiation-Based Conditioning Followed by Two-Step Haploidentical Stem Cell Transplant, Results of a Prospective Trial

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2024-10-010

PRE

Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation

种族和民族对脐血移植后结局的影响

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2024-10-010

PRE

Ballen, Karen; Wang, Tao; He, Naya; Knight, Jennifer M.; Hong, Sanghee; Frangoul, Haydar; Verdonck, Leo F.; Steinberg, Amir; Diaz, Miguel A.; Lemaistre, C. Fred; Badawy, Sherif M.; Pu, Jeffrey J.; Hashem, Hasan; Savani, Bipin; Sharma, Akshay; Lazarus, Hillard M.; Abid, Muhammad Bilal; Tay, Jason; Rangarajan, Hemalatha G.; Kindwall-Keller, Tamila; Freytes, Cesar O.; Beitinjaneh, Amer; Winestone, Lena E.; Gergis, Usama; Farhadfar, Nosha; Bhatt, Neel S.; Schears, Raquel M.; Gomez-Almaguer, David; Aljurf, Mahmoud; Agrawal, Vaibhav; Kuwatsuka, Yachiyo; Seo, Sachiko; Marks, David I.; Lehmann, Leslie; Wood, William A.; Hashmi, Shahrukh; Saber, Wael

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

BLOOD ADVANCES

IF7.1

2024-08-142

OAAI

Jain, Tania; Estrada-Merly, Noel; Salas, M. Queralt; Kim, Soyoung; Devos, Jakob; Chen, Min; Fang, Xi; Kumar, Rajat; Andrade-Campos, Marcio; Elmariah, Hany; Agrawal, Vaibhav; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M.; Ballen, Karen; Beitinjaneh, Amer; Bhatt, Vijaya Raj; Bredeson, Christopher; Defilipp, Zachariah; Dholaria, Bhagirathbhai; Farhadfar, Nosha; Farhan, Shatha; Gandhi, Arpita P.; Ganguly, Siddhartha; Gergis, Usama; Grunwald, Michael R.; Hamad, Nada; Hamilton, Betty K.; Inamoto, Yoshihiro; Iqbal, Madiha; Jamy, Omer; Juckett, Mark; Kharfan-Dabaja, Mohamed A.; Krem, Maxwell M.; Lad, Deepesh P.; Liesveld, Jane; Malki, Monzr M. Al; Malone, Adriana K.; Murthy, Hemant S.; Orti, Guillermo; Patel, Sagar S.; Pawarode, Attaphol; Perales, Miguel-Angel; van der Poel, Marjolein; Ringden, Olle; Rizzieri, David A.; Rovoa, Alicia; Savani, Bipin N.; Savoie, Mary Lynn; Seo, Sachiko; Solh, Melhem; Ustun, Celalettin; Verdonck, Leo F.; Wingard, John R.; Wirk, Baldeep; Bejanyan, Nelli; Jones, Richard J.; Nishihori, Taiga; Oran, Betul; Nakamura, Ryotaro; Scott, Bart; Saber, Wael; Gupta, Vikas

Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19

BLOOD ADVANCES

IF7.1

2024-08-010

OAAI

Chimeric Antigen Receptor T-Cell Access in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Association of Access with Social Determinants of Health and Travel Time to Treatment Centers

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2024-07-015

PRE

Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies (vol 41, pg 1637, 2024)

ADVANCES IN THERAPY